Inhibition of protein phosphatase 2A (PP2A) in human AD patients seems to be an important factor in the disease progression, as PP2A is considered the major tau phosphatase essential for regulating tau phosphorylation [11]. The gene discussed is MAPT; the disease is Alzheimer disease.